NCT00399061 - Efficacy of Optive Versus Systane Concomitant With Restasis (Cyclosporine A) for the Treatment of Dry Eye Symptoms | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions

Dry Eye

Interventions

DRUG

Systane, Optive, Restasis

Systane 30ml (in the eye) instill one drop twice a day in morning and evening Optive 15ml (in the eye) instill one drop twice a day in morning and evening Restasis 0.4ml (in the eye) instill one drop twice a day in morning and evening more frequently if needed

Trial Locations (1)

12159

Dr. Schultze, Slingerlands